Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 723946, 11 pages
http://dx.doi.org/10.1155/2015/723946
Research Article

Experimental Immunization Based on Plasmodium Antigens Isolated by Antibody Affinity

1Department of Biochemistry and Molecular Biology IV, Universidad Complutense de Madrid, Facultad de Veterinaria, Ciudad Universitaria, 28040 Madrid, Spain
2Department of Biology, Faculty of Basic Sciences, Islamic Azad University, Central Tehran Branch, Tehran 14676-86831, Iran
3Department of Medicine and Surgery, Psychology, Preventive Medicine and Public Health and Medical Immunology and Microbiology, Faculty of Health Sciences, Universidad Rey Juan Carlos, Alcorcón, 28922 Madrid, Spain
4Research Institute Hospital 12 de Octubre, Universidad Complutense de Madrid, 28040 Madrid, Spain

Received 25 June 2015; Accepted 25 August 2015

Academic Editor: Yoshihiko Hoshino

Copyright © 2015 Ali N. Kamali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Doolan, C. Dobano, and J. K. Baird, “Acquired immunity to malaria,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 13–36, 2009. View at Publisher · View at Google Scholar
  2. H. Hisaeda, K. Yasutomo, and K. Himeno, “Malaria: immune evasion by parasites,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 4, pp. 700–706, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. N. J. White, S. Pukrittayakamee, T. T. Hien, M. A. Faiz, O. A. Mokuolu, and A. M. Dondorp, “Malaria,” The Lancet, vol. 383, no. 9918, pp. 723–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. L. Richie and A. Saul, “Progress and challenges for malaria vaccines,” Nature, vol. 415, no. 6872, pp. 694–701, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. D. L. Doolan, Y. Mu, B. Unal et al., “Profiling humoral immune responses to P. falciparum infection with protein microarrays,” Proteomics, vol. 8, no. 22, pp. 4680–4694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Langhorne, F. M. Ndungu, A.-M. Sponaas, and K. Marsh, “Immunity to malaria: more questions than answers,” Nature Immunology, vol. 9, no. 7, pp. 725–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. C. Gray, P. H. Corran, E. Mangia et al., “Profiling the antibody immune response against blood stage malaria vaccine candidates,” Clinical Chemistry, vol. 53, no. 7, pp. 1244–1253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Riley and V. A. Stewart, “Immune mechanisms in malaria: new insights in vaccine development,” Nature Medicine, vol. 19, no. 2, pp. 168–178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Good, “A whole parasite vaccine to control the blood stages of Plasmodium—the case for lateral thinking,” Trends in Parasitology, vol. 27, no. 8, pp. 335–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Rénia, A. C. Grüner, M. Mauduit, and G. Snounou, “Vaccination against malaria with live parasites,” Expert Review of Vaccines, vol. 5, no. 4, pp. 473–481, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. F. Good and D. L. Doolan, “Malaria vaccine design: immunological considerations,” Immunity, vol. 33, no. 4, pp. 555–566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Burns Jr., P. D. Dunn, and D. M. Russo, “Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens,” Infection and Immunity, vol. 65, no. 8, pp. 3138–3145, 1997. View at Google Scholar · View at Scopus
  13. D. J. Pombo, G. Lawrence, C. Hirunpetcharat et al., “Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum,” The Lancet, vol. 360, no. 9333, pp. 610–617, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Roestenberg, A. C. Teirlinck, M. B. B. McCall et al., “Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study,” The Lancet, vol. 377, no. 9779, pp. 1770–1776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Pinzon-Charry, V. McPhun, V. Kienzle et al., “Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice,” The Journal of Clinical Investigation, vol. 120, no. 8, pp. 2967–2978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. L. M. ten Hagen, A. J. Sulzer, M. R. Kidd, A. A. Lal, and R. L. Hunter, “Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines,” Journal of Immunology, vol. 151, no. 12, pp. 7077–7085, 1993. View at Google Scholar · View at Scopus
  17. J. Yuan, B. Xu, and B.-F. Liu, “Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii,” Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 26, no. 1, pp. 47–51, 2004. View at Google Scholar · View at Scopus
  18. M. J. Gardner, N. Hall, E. Fung et al., “Genome sequence of the human malaria parasite Plasmodium falciparum,” Nature, vol. 419, no. 6906, pp. 498–511, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. D. L. Doolan, “Plasmodium immunomics,” International Journal for Parasitology, vol. 41, no. 1, pp. 3–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. I. G. Azcárate, P. Marín-García, A. N. Kamali et al., “Differential immune response associated to malaria outcome is detectable in peripheral blood following plasmodium yoelii infection in mice,” PLoS ONE, vol. 9, no. 1, Article ID e85664, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. N. Kamali, P. Marín-García, I. G. Azcárate, A. Diez, A. Puyet, and J. M. Bautista, “Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice,” Immunobiology, vol. 217, no. 8, pp. 823–830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Kilkenny, W. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, “Animal research: reporting in vivo experiments: the ARRIVE guidelines,” British Journal of Pharmacology, vol. 160, no. 7, pp. 1577–1579, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. G. A. Kicska, L.-M. Ting, V. L. Schramm, and K. Kim, “Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection,” Journal of Infectious Diseases, vol. 188, no. 11, pp. 1776–1781, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. A. W. Taylor-Robinson, “Regulation of immunity to malaria: valuable lessons learned from murine models,” Parasitology Today, vol. 11, no. 9, pp. 334–342, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Holder and R. R. Freeman, “Immunization against blood-stage rodent malaria using purified parasite antigens,” Nature, vol. 294, no. 5839, pp. 361–364, 1981. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Weeratna, L. Comanita, and H. L. Davis, “CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice,” Immunology and Cell Biology, vol. 81, no. 1, pp. 59–62, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. R. E. Bégué and H. Sadowska-Krowicka, “Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model,” FEMS Immunology and Medical Microbiology, vol. 60, no. 2, pp. 142–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Cohen, I. A. McGregor, and S. Carrington, “Gamma-globulin and acquired immunity to human malaria,” Nature, vol. 192, no. 4804, pp. 733–737, 1961. View at Publisher · View at Google Scholar · View at Scopus
  29. A. N. Jayawardena, G. A. T. Targett, E. Leuchars, and A. J. S. Davies, “The immunological response of CBA mice to P. yoelii. II. The passive transfer of immunity with serum and cells,” Immunology, vol. 34, no. 1, pp. 157–165, 1978. View at Google Scholar · View at Scopus
  30. WHO, World Malaria Report, World Health Organization, Geneva, Switzerland, 2012.
  31. A. Trieu, M. A. Kayala, C. Burk et al., “Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens,” Molecular & Cellular Proteomics, vol. 10, no. 9, Article ID M111.007948, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. L. Hoffman, L. M. L. Goh, T. C. Luke et al., “Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites,” Journal of Infectious Diseases, vol. 185, no. 8, pp. 1155–1164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. A.-K. Mueller, M. Labaled, S. H. I. Kappe, and K. Matuschewski, “Genetically modified Plasmodium parasites as a protective experimental malaria vaccine,” Nature, vol. 433, no. 7022, pp. 164–167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Roestenberg, M. McCall, J. Hopman et al., “Protection against a malaria challenge by sporozoite inoculation,” The New England Journal of Medicine, vol. 361, no. 5, pp. 468–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. F. I. Weinbaum, C. B. Evans, and R. E. Tigelaar, “Immunity to Plasmodium berghei yoelii in mice. I. The course of infection in T cell and B cell deficient mice,” Journal of Immunology, vol. 117, no. 5, part 2, pp. 1999–2005, 1976. View at Google Scholar · View at Scopus
  36. P. Perlmann and M. Troye-Blomberg, “Malaria and the immune system in humans,” Chemical Immunology, vol. 80, pp. 229–242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Bejon, J. Mwacharo, O. Kai et al., “A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya,” PLoS Clinical Trials, vol. 1, no. 6, article e29, 2006. View at Publisher · View at Google Scholar
  38. E. Belnoue, T. Voza, F. T. M. Costa et al., “Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage,” The Journal of Immunology, vol. 181, no. 12, pp. 8552–8558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. O. P. Alexandre, L. M. A. Camargo, D. Mattei et al., “Humoral immune response to the 72 kDa heat shock protein from Plasmodium falciparum in populations at hypoendemic areas of malaria in western Brazilian Amazon,” Acta Tropica, vol. 64, no. 3-4, pp. 155–166, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Banumathy, V. Singh, S. R. Pavithra, and U. Tatu, “Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes,” Journal of Biological Chemistry, vol. 278, no. 20, pp. 18336–18345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Tardieux, I. Baines, M. Mossakowska, and G. E. Ward, “Actin-binding proteins of invasive malaria parasites and the regulation of actin polymerization by a complex of 32/34-kDa proteins associated with heat shock protein 70kDa,” Molecular and Biochemical Parasitology, vol. 93, no. 2, pp. 295–308, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Mata, M. Igartua, R. M. Hernández, J. E. Rosas, M. E. Patarroyo, and J. L. Pedraz, “Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides,” Drug Delivery, vol. 17, no. 7, pp. 490–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Rafi-Janajreh, J. E. Tongren, C. Kensil et al., “Influence of adjuvants in inducing immune responses to different epitopes included in a multiepitope, multivalent, multistage Plasmodium falciparum candidate vaccine (FALVAC-1) in outbred mice,” Experimental Parasitology, vol. 101, no. 1, pp. 3–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Yang, W. E. Collins, L. Xiao et al., “Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1),” Parasite Immunology, vol. 18, no. 11, pp. 547–558, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Scheiermann and D. M. Klinman, “Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer,” Vaccine, vol. 32, no. 48, pp. 6377–6389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Tighe, K. Takabayashi, D. Schwartz et al., “Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity,” European Journal of Immunology, vol. 30, no. 7, pp. 1939–1947, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Roman, E. Martin-Orozco, J. S. Goodman et al., “Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants,” Nature Medicine, vol. 3, no. 8, pp. 849–854, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Shirota, K. Sano, N. Hirasawa et al., “Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells,” The Journal of Immunology, vol. 167, no. 1, pp. 66–74, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Billiau and P. Matthys, “Modes of action of Freund's adjuvants in experimental models of autoimmune diseases,” Journal of Leukocyte Biology, vol. 70, no. 6, pp. 849–860, 2001. View at Google Scholar · View at Scopus
  50. G. Wolberg, C. T. Liu, and F. L. Adler, “Passive hemagglutination. II. Titration of antibody against determinants unique for aggregated denatured bovine serum albumin and further studies on gelatin,” Journal of Immunology, vol. 105, no. 4, pp. 797–801, 1970. View at Google Scholar · View at Scopus
  51. M. Linares, E. Albizua, D. Méndez et al., “Malaria hidden in a patient with diffuse large B-cell lymphoma and sickle cell trait,” Journal of Clinical Microbiology, vol. 49, no. 12, pp. 4401–4404, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. T. von der Weid, N. Honarvar, and J. Langhorne, “Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection,” Journal of Immunology, vol. 156, no. 7, pp. 2510–2516, 1996. View at Google Scholar · View at Scopus
  53. J. Wipasa, S. Elliott, H. Xu, and M. F. Good, “Immunity to asexual blood stage malaria and vaccine approaches,” Immunology and Cell Biology, vol. 80, no. 5, pp. 401–414, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. R. W. Sauerwein, E. M. Bijker, and T. L. Richie, “Empowering malaria vaccination by drug administration,” Current Opinion in Immunology, vol. 22, no. 3, pp. 367–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. G. Beeson, F. H. A. Osier, and C. R. Engwerda, “Recent insights into humoral and cellular immune responses against malaria,” Trends in Parasitology, vol. 24, no. 12, pp. 578–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. K. E. Kester, J. F. Cummings, O. Ofori-Anyinam et al., “Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection,” Journal of Infectious Diseases, vol. 200, no. 3, pp. 337–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Ansong, K. P. Asante, J. Vekemans et al., “T cell responses to the RTS,S/AS01E and RTS,S/AS02D malaria candidate vaccines administered according to different schedules to Ghanaian children,” PLoS ONE, vol. 6, no. 4, Article ID e18891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. J. M. Lumsden, R. J. Schwenk, L. E. Rein et al., “Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4+ T cells,” PLoS ONE, vol. 6, no. 7, Article ID e20775, 2011. View at Publisher · View at Google Scholar · View at Scopus